市場調查報告書

照護現場(POC)脂質檢驗的全球市場

POC Lipid Testing

出版商 Global Industry Analysts, Inc. 商品編碼 941114
出版日期 內容資訊 英文 192 Pages
商品交期: 最快1-2個工作天內
價格
照護現場(POC)脂質檢驗的全球市場 POC Lipid Testing
出版日期: 2020年07月01日內容資訊: 英文 192 Pages
簡介

COVID-19危機中,2020年估算為2億3,880萬美元的照護現場(POC)脂質檢驗全球市場,在2020年∼2027年的期間中預計將以2.9%的年複合成長率增長,2027年達到2億9,220萬美元。市場區隔之一的高血脂症部門在分析期間結束前預測將以2.7%的年複合成長率增長,達到8,710萬美元。

本報告提供照護現場(POC)脂質檢驗的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的變化與預測,各種區分·地區·各主要國家的詳細分析,競爭環境,主要企業簡介等資訊。

調查對象企業範例

  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Abaxis, Inc.
  • Accutech LLC
  • Alere, Inc.
  • Biochemical Systems International Srl
  • Bio-Rad Laboratories, Inc.
  • Eurotrol B.V.
  • F. Hoffmann-La Roche AG
  • General Life Biotechnology Co., Ltd.
  • Helena Laboratories Corporation
  • Nova Biomedical Corporation

目錄

I. 簡介,調查手法 、調查範圍

II. 摘要整理

第1章 市場概要

  • 全球其他競爭公司的市場佔有率
  • 市場佔有率方案:2019&2025
  • Covid-19的影響和即將到來的全球景氣衰退

第2章 主要企業

第3章 市場趨勢與推動因素

第4章 全球市場預測

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

IV. 競爭

  • 企業簡介:42公司
目錄
Product Code: MCP14040

Global POC Lipid Testing Market to Reach $292.2 Million by 2027

Amid the COVID-19 crisis, the global market for POC Lipid Testing estimated at US$238.8 Million in the year 2020, is projected to reach a revised size of US$292.2 Million by 2027, growing at a CAGR of 2.9% over the analysis period 2020-2027. Hyperlipidemia, one of the segments analyzed in the report, is projected to record a 2.7% CAGR and reach US$87.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hypertriglyceridemia segment is readjusted to a revised 3.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $64.6 Million, While China is Forecast to Grow at 5.3% CAGR

The POC Lipid Testing market in the U.S. is estimated at US$64.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$59.1 Million by the year 2027 trailing a CAGR of 5.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.8% and 2.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Familial Hypercholesterolemia Segment to Record 3.3% CAGR

In the global Familial Hypercholesterolemia segment, USA, Canada, Japan, China and Europe will drive the 2.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$30.6 Million in the year 2020 will reach a projected size of US$37.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$40.4 Million by the year 2027, while Latin America will expand at a 4.1% CAGR through the analysis period. We bring years of research experience to this 6th edition of our report. The 192-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Abaxis, Inc.
  • Accutech LLC
  • Alere, Inc.
  • Biochemical Systems International Srl
  • Bio-Rad Laboratories, Inc.
  • Eurotrol B.V.
  • F. Hoffmann-La Roche AG
  • General Life Biotechnology Co., Ltd.
  • Helena Laboratories Corporation
  • Nova Biomedical Corporation

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • POC Lipid Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: POC Lipid Testing Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: POC Lipid Testing Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
  • TABLE 3: POC Lipid Testing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Hyperlipidemia (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
  • TABLE 5: Hyperlipidemia (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 6: Hyperlipidemia (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Hypertriglyceridemia (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
  • TABLE 8: Hypertriglyceridemia (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019
  • TABLE 9: Hypertriglyceridemia (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
  • TABLE 10: Familial Hypercholesterolemia (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 11: Familial Hypercholesterolemia (Application) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 12: Familial Hypercholesterolemia (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Hyperlipoproteinemia (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 14: Hyperlipoproteinemia (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 15: Hyperlipoproteinemia (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Tangier disease (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 17: Tangier disease (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 18: Tangier disease (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Other Applications (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
  • TABLE 20: Other Applications (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019
  • TABLE 21: Other Applications (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US POC Lipid Testing Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 22: United States POC Lipid Testing Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
    • TABLE 23: POC Lipid Testing Historic Demand Patterns in the United States by Application in US$ Thousand for 2012-2019
    • TABLE 24: POC Lipid Testing Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 25: Canadian POC Lipid Testing Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 26: POC Lipid Testing Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019
    • TABLE 27: Canadian POC Lipid Testing Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 28: Japanese Demand Estimates and Forecasts for POC Lipid Testing in US$ Thousand by Application: 2020 to 2027
    • TABLE 29: Japanese POC Lipid Testing Market in US$ Thousand by Application: 2012-2019
    • TABLE 30: POC Lipid Testing Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 31: Chinese Demand for POC Lipid Testing in US$ Thousand by Application: 2020 to 2027
    • TABLE 32: POC Lipid Testing Market Review in China in US$ Thousand by Application: 2012-2019
    • TABLE 33: Chinese POC Lipid Testing Market Share Breakdown by Application: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European POC Lipid Testing Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 34: European POC Lipid Testing Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
    • TABLE 35: POC Lipid Testing Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 36: European POC Lipid Testing Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 37: European POC Lipid Testing Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 38: POC Lipid Testing Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019
    • TABLE 39: European POC Lipid Testing Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 40: POC Lipid Testing Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027
    • TABLE 41: French POC Lipid Testing Historic Market Review in US$ Thousand by Application: 2012-2019
    • TABLE 42: French POC Lipid Testing Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
  • GERMANY
    • TABLE 43: POC Lipid Testing Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
    • TABLE 44: German POC Lipid Testing Market in Retrospect in US$ Thousand by Application: 2012-2019
    • TABLE 45: POC Lipid Testing Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 46: Italian Demand for POC Lipid Testing in US$ Thousand by Application: 2020 to 2027
    • TABLE 47: POC Lipid Testing Market Review in Italy in US$ Thousand by Application: 2012-2019
    • TABLE 48: Italian POC Lipid Testing Market Share Breakdown by Application: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 49: United Kingdom Demand Estimates and Forecasts for POC Lipid Testing in US$ Thousand by Application: 2020 to 2027
    • TABLE 50: United Kingdom POC Lipid Testing Market in US$ Thousand by Application: 2012-2019
    • TABLE 51: POC Lipid Testing Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
  • SPAIN
    • TABLE 52: Spanish POC Lipid Testing Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 53: POC Lipid Testing Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019
    • TABLE 54: Spanish POC Lipid Testing Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • RUSSIA
    • TABLE 55: Russian POC Lipid Testing Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
    • TABLE 56: POC Lipid Testing Historic Demand Patterns in Russia by Application in US$ Thousand for 2012-2019
    • TABLE 57: POC Lipid Testing Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 58: Rest of Europe POC Lipid Testing Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 59: POC Lipid Testing Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019
    • TABLE 60: Rest of Europe POC Lipid Testing Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 61: Asia-Pacific POC Lipid Testing Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 62: POC Lipid Testing Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 63: Asia-Pacific POC Lipid Testing Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 64: POC Lipid Testing Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027
    • TABLE 65: Asia-Pacific POC Lipid Testing Historic Market Review in US$ Thousand by Application: 2012-2019
    • TABLE 66: Asia-Pacific POC Lipid Testing Market Share Analysis: A 17-Year Perspectiveby Application for 2012, 2020, and 2027
  • AUSTRALIA
    • TABLE 67: POC Lipid Testing Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
    • TABLE 68: Australian POC Lipid Testing Market in Retrospect in US$ Thousand by Application: 2012-2019
    • TABLE 69: POC Lipid Testing Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027
  • INDIA
    • TABLE 70: Indian POC Lipid Testing Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 71: POC Lipid Testing Market in India: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019
    • TABLE 72: Indian POC Lipid Testing Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • SOUTH KOREA
    • TABLE 73: POC Lipid Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2020-2027
    • TABLE 74: South Korean POC Lipid Testing Historic Market Analysis in US$ Thousand by Application: 2012-2019
    • TABLE 75: POC Lipid Testing Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027
  • REST OF ASIA-PACIFIC
    • TABLE 76: Rest of Asia-Pacific Demand Estimates and Forecasts for POC Lipid Testing in US$ Thousand by Application: 2020 to 2027
    • TABLE 77: Rest of Asia-Pacific POC Lipid Testing Market in US$ Thousand by Application: 2012-2019
    • TABLE 78: POC Lipid Testing Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027
  • LATIN AMERICA
    • TABLE 79: Latin American POC Lipid Testing Market Trends by Region/Country in US$ Thousand: 2020-2027
    • TABLE 80: POC Lipid Testing Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019
    • TABLE 81: Latin American POC Lipid Testing Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    • TABLE 82: Latin American Demand for POC Lipid Testing in US$ Thousand by Application: 2020 to 2027
    • TABLE 83: POC Lipid Testing Market Review in Latin America in US$ Thousand by Application: 2012-2019
    • TABLE 84: Latin American POC Lipid Testing Market Share Breakdown by Application: 2012 VS 2020 VS 2027
  • ARGENTINA
    • TABLE 85: Argentinean POC Lipid Testing Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 86: POC Lipid Testing Market in Argentina: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019
    • TABLE 87: Argentinean POC Lipid Testing Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • BRAZIL
    • TABLE 88: POC Lipid Testing Quantitative Demand Analysis in Brazil in US$ Thousand by Application: 2020-2027
    • TABLE 89: Brazilian POC Lipid Testing Historic Market Review in US$ Thousand by Application: 2012-2019
    • TABLE 90: Brazilian POC Lipid Testing Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
  • MEXICO
    • TABLE 91: POC Lipid Testing Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
    • TABLE 92: Mexican POC Lipid Testing Market in Retrospect in US$ Thousand by Application: 2012-2019
    • TABLE 93: POC Lipid Testing Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027
  • REST OF LATIN AMERICA
    • TABLE 94: Rest of Latin America POC Lipid Testing Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
    • TABLE 95: POC Lipid Testing Historic Demand Patterns in Rest of Latin America by Application in US$ Thousand for 2012-2019
    • TABLE 96: POC Lipid Testing Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027
  • MIDDLE EAST
    • TABLE 97: The Middle East POC Lipid Testing Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 98: POC Lipid Testing Market in the Middle East by Region/Country in US$ Thousand: 2012-2019
    • TABLE 99: The Middle East POC Lipid Testing Market Share Breakdown by Region/Country: 2012, 2020, and 2027
    • TABLE 100: The Middle East POC Lipid Testing Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
    • TABLE 101: POC Lipid Testing Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019
    • TABLE 102: The Middle East POC Lipid Testing Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • IRAN
    • TABLE 103: Iranian Demand Estimates and Forecasts for POC Lipid Testing in US$ Thousand by Application: 2020 to 2027
    • TABLE 104: Iranian POC Lipid Testing Market in US$ Thousand by Application: 2012-2019
    • TABLE 105: POC Lipid Testing Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027
  • ISRAEL
    • TABLE 106: Israeli POC Lipid Testing Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
    • TABLE 107: POC Lipid Testing Market in Israel: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019
    • TABLE 108: Israeli POC Lipid Testing Market Share Analysis by Application: 2012 VS 2020 VS 2027
  • SAUDI ARABIA
    • TABLE 109: Saudi Arabian Demand for POC Lipid Testing in US$ Thousand by Application: 2020 to 2027
    • TABLE 110: POC Lipid Testing Market Review in Saudi Arabia in US$ Thousand by Application: 2012-2019
    • TABLE 111: Saudi Arabian POC Lipid Testing Market Share Breakdown by Application: 2012 VS 2020 VS 2027
  • UNITED ARAB EMIRATES
    • TABLE 112: POC Lipid Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2020-2027
    • TABLE 113: United Arab Emirates POC Lipid Testing Historic Market Analysis in US$ Thousand by Application: 2012-2019
    • TABLE 114: POC Lipid Testing Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027
  • REST OF MIDDLE EAST
    • TABLE 115: POC Lipid Testing Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
    • TABLE 116: Rest of Middle East POC Lipid Testing Market in Retrospect in US$ Thousand by Application: 2012-2019
    • TABLE 117: POC Lipid Testing Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027
  • AFRICA
    • TABLE 118: African POC Lipid Testing Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
    • TABLE 119: POC Lipid Testing Historic Demand Patterns in Africa by Application in US$ Thousand for 2012-2019
    • TABLE 120: POC Lipid Testing Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 42